Current state: 2026.
The regulatory text converged around ICH M10. Inspection practice still depends on region, study context, matrix, modality, and documentation maturity. This page separates official anchors from iFeed interpretation and observed inspection themes.
Current state: 2026.
What's live · what just changed · what's in transitionThe regulatory text converged around ICH M10. Inspection practice still depends on region, study context, matrix, modality, and documentation maturity. This page separates official anchors from iFeed interpretation and observed inspection themes.
ICH M10.
ICH M10 is the central harmonised text for bioanalytical method validation and study sample analysis. The common acceptance logic includes calibration standard and QC expectations, LLOQ handling, incurred sample reanalysis principles, and study-sample analysis controls.
M10 + 2018 context.
FDA has an official M10 guidance page and still hosts the May 2018 Bioanalytical Method Validation guidance. Public iFeed wording should treat them as FDA source anchors and avoid implying a replacement relationship unless an FDA source says so directly.
ICH M10 implementation.
EMA has an official ICH M10 scientific-guideline page. The earlier EMA Rev.1 BMV guideline remains useful for historical comparison, but current EU-facing content should clearly mark it as a historical/superseded reference.
M10 implementation check.
Japanese implementation details should be anchored to the official MHLW/PMDA source before making region-specific interpretation claims. iFeed can track differences in practice, but inspector-behaviour statements need source or dataset support.
Current source stack.
Brazil-specific expectations should be checked against the current ANVISA source stack, including RDC 742/2022 and any current guidance or Q&A. Older RDC 27/2012 material should be labelled as historical or legacy unless still applicable.
Prequalification context.
WHO should be presented as a WHO/PQT source family rather than as a regulator equivalent to FDA or EMA. For public pages, WHO-specific claims need the current WHO PQT or TRS anchor visible next to the interpretation.
ISR sample selection.
Public 483s and Warning Letters show recurring scrutiny around ISR sample selection, randomisation defensibility, concentration-range coverage, and time-point distribution. Percentage claims should stay internal until the iFeed dataset and denominator are published.
Reagent-lot bridging.
Critical-reagent transitions remain a practical evidence gap: which lot was validated, which lot ran study samples, and what bridging experiment closed the change-control record.
Partial-validation SOP gaps.
Partial-validation findings usually begin as documentation questions: were triggers predefined, were acceptance criteria justified, and was the change tied to matrix, anticoagulant, site transfer, reagent change, or platform change?
Method-transfer documentation.
Sponsor-to-CRO and CRO-to-CRO transfers need a controlled evidence trail. The public page should present this as an evidence-readiness issue unless a specific regulator finding is cited.
QMSR interface.
FDA QMSR becomes effective in 2026 and strengthens the design-control context for medical devices. iFeed interpretation: combination-product teams may need clearer mapping between design-control records and bioanalytical evidence where product claims depend on bioanalytical data.
Advanced-modality bioanalytics.
Cell and gene therapy bioanalytics, vector-copy-number assays, and anti-vector immunogenicity remain active watch areas. Public claims about formal EMA/FDA/PMDA/ANVISA positions should be held as watch items until source-linked.
Source anchors: ICH M10 Step 4 guideline · FDA M10 guidance page · FDA 2018 BMV guidance · EMA ICH M10 page. iFeed inspection themes are analysis records, not FDA-published category statistics.
Source register.
official anchors · interpretation kept separateThis bioanalytical page uses official guidance as the source layer and separates iFeed interpretation from regulator text. Jurisdiction-specific details should be checked against the current regulator page before use in submissions, audits, or public checklists.
ICH M10 EU page.
EMA ICH M10 scientific guideline. Earlier EMA BMV guidance should be marked as historical where used for comparison.